Only one literature concentrating on the specific role of CRP, a recognised measure of systemic inflammation and hypercatabolism, has been found to predict QOL to our knowledge [33].The following variables independently predicted the QOL of the patients according to a multivariate analysis; for example, anorexia medications in the pipeline include anamorelin, an oral ghrelin-receptor agonist with appetite-stimulating and anabolic properties [34], thereby people's quality of life should be improved. The gene discussed is CRP; the disease is Anorexia.